Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2024

Apr 12, 2024

35106_dirs_2024-04-12_989ad0d3-4d0e-4df8-90b1-02039384caf4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2024-04-05

Reporting Person: ST. CLAIR GREGORY SR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-04-05 Common Stock A 3268 Acquired 22534 Direct